Intervention not reported
Mirtazapine standard dose RCTs: 1 Participants: 422 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Low
Intervention not reported
Duloxetine low dose RCTs: 6 Participants: 1116 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
6 participants
Moderate
Intervention not reported
Esreboxetine high dose RCTs: 1 Participants: 555 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Very low
Number of participants reporting an adverse event · people with episodic migraine
Acupuncture showed no clear difference in number of participants reporting adverse effects compared with sham interventions (high certainty).
1 finding from 1 review
Headache (frequency) · people with episodic migraine
2 findings from 1 review
Response (after treatment) · people with episodic migraine
Acupuncture probably leads to higher response (after treatment) compared with sham interventions (moderate certainty).
1 finding from 1 review
Response ( · people with episodic migraine
Acupuncture probably leads to higher response ( compared with sham interventions (moderate certainty).
1 finding from 1 review
Adverse effects (drop‐outs due to adverse effects4) · people with episodic migraine
Acupuncture showed no clear difference in number of participants dropping out due to adverse effects compared with sham interventions (low certainty).
1 finding from 1 review
Duration of crying (seconds) · Infants 1 to 12 months during vaccination
1 finding from 1 review
All pain scores during injection Due to range of pain scores used, data analysed using SMDs. Pain scores were measured during and up to 3 minutes following completion of vaccination. · Infants 1 to 12 months during vaccination
2 findings from 1 review
Heart rate · Infants 1 to 12 months during vaccination
1 finding from 1 review
Adverse events · Infants 1 to 12 months during vaccination
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pruritus · health problem or population
1 finding from 1 review
Pruritus · patients with chronic kidney disease (CKD) pruritus
1 finding from 1 review
Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pruritus · patients with chronic kidney disease (CKD) pruritus
1 finding from 1 review
Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found